These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36175948)

  • 1. Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort study.
    Yoshida H; Motohashi T; De Bus L; De Waele J; Takaba A; Kuriyama A; Kobayashi A; Tanaka C; Hashi H; Hashimoto H; Nashiki H; Shibata M; Kanamoto M; Inoue M; Hashimoto S; Katayama S; Fujiwara S; Kameda S; Shindo S; Suzuki T; Komuro T; Kawagishi T; Kawano Y; Fujita Y; Kida Y; Hara Y; Fujitani S;
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):119. PubMed ID: 36175948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antimicrobial therapy in the intensive care unit based on the risk of multidrug-resistant bacterial infection: a single-centre case‒control study of blood culture results in Japan.
    Nanao T; Nishizawa H; Fujimoto J
    Antimicrob Resist Infect Control; 2023 Sep; 12(1):99. PubMed ID: 37697404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.
    Ishii J; Nishikimi M; De Bus L; De Waele J; Takaba A; Kuriyama A; Kobayashi A; Tanaka C; Hashi H; Hashimoto H; Nashiki H; Shibata M; Kanamoto M; Inoue M; Hashimoto S; Katayama S; Fujiwara S; Kameda S; Shindo S; Komuro T; Kawagishi T; Kawano Y; Fujita Y; Kida Y; Hara Y; Yoshida H; Fujitani S; Shime N;
    Microbiol Spectr; 2024 Jul; 12(7):e0034224. PubMed ID: 38864641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
    Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
    BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study.
    Kreitmann L; Vasseur M; Jermoumi S; Perche J; Richard JC; Wallet F; Chabani M; Nourry E; Garçon P; Zerbib Y; Van Grunderbeeck N; Vinsonneau C; Preda C; Labreuche J; Nseir S
    Intensive Care Med; 2023 Feb; 49(2):154-165. PubMed ID: 36592202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis.
    De Bus L; Saerens L; Gadeyne B; Boelens J; Claeys G; De Waele JJ; Benoit DD; Decruyenaere J; Depuydt PO
    Crit Care; 2014 Jul; 18(4):R152. PubMed ID: 25030270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
    Nseir S; Grailles G; Soury-Lavergne A; Minacori F; Alves I; Durocher A
    Clin Microbiol Infect; 2010 Jul; 16(7):902-8. PubMed ID: 19694760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.
    Rello J; Sarda C; Mokart D; Arvaniti K; Akova M; Tabah A; Azoulay E;
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):385-392. PubMed ID: 31707508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between COVID-19 and ICU-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter before-after study.
    Kreitmann L; Jermoumi S; Vasseur M; Chabani M; Nourry E; Richard JC; Wallet F; Garçon P; Kachmar S; Zerbib Y; Van Grunderbeeck N; Vinsonneau C; Duhamel A; Labreuche J; Nseir S
    Intensive Care Med; 2023 Jul; 49(7):796-807. PubMed ID: 37326645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
    Kim JW; Chung J; Choi SH; Jang HJ; Hong SB; Lim CM; Koh Y
    Crit Care; 2012 Feb; 16(1):R28. PubMed ID: 22336530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study.
    Nseir S; Di Pompeo C; Diarra M; Brisson H; Tissier S; Boulo M; Durocher A
    Crit Care Med; 2007 May; 35(5):1318-23. PubMed ID: 17414081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
    Daneman N; Sarwar S; Fowler RA; Cuthbertson BH;
    Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
    Costa Pde O; Atta EH; Silva AR
    J Pediatr (Rio J); 2015; 91(5):435-41. PubMed ID: 26057184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock.
    Routsi C; Gkoufa A; Arvaniti K; Kokkoris S; Tourtoglou A; Theodorou V; Vemvetsou A; Kassianidis G; Amerikanou A; Paramythiotou E; Potamianou E; Ntorlis K; Kanavou A; Nakos G; Hassou E; Antoniadou H; Karaiskos I; Prekates A; Armaganidis A; Pnevmatikos I; Kyprianou M; Zakynthinos S; Poulakou G; Giamarellou H
    J Antimicrob Chemother; 2020 Dec; 75(12):3665-3674. PubMed ID: 32865203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
    De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
    Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.